Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

Clinical trial NCT01138124 · COMPLETED

Trial details

NCT number: NCT01138124
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Pelvis Cancer Restless Legs Syndrome Epilepsy Neuropathic Pain Chronic Pancreatitis Hypertension Pancreatic Cancer Diabetes Renal Cancer Renal Cell Carcinoma

Start date: 2010-03-01
Primary completion: 2010-08-01
Enrollment: 54202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.